Abstract:Objective To evaluate the relevance of molecular alterations and histopathological subtypes of lung adenocarcinoma according to 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. Methods Mutations of epidermal growth factor receptor (EGFR) 18-21 exons ( E18-21 ),KRAS 12/13 codons and EML4-ALK fusion in 212 cases of lung adenocarcinoma which underwent complete tumor resection,were detected by immunohistochemistry,PCR-amplifying and gene sequencing.The relevance of the molecular alterations to histopathological subtypes based on the new classification and 2004 WHO classification were further characterized. Results Mutations of EGFR were observed in 49.6％ of lung adenocarcinomas,involving mainly E21 (52.4％,55/105 ) and E19 ( 36.2％,38/105). Mutations of KRAS were detected in 8％ cases of adenocarcinoma,involving mainly codon 12 (15/17). EML4-ALK fusions were found in 6.1％ of lung adenocarcinoma,the most common fusion mutation was type V1 ( E13; A20) (7/13),followed by type V3a/b ( E6a/b; A20) (4/13).Based on the new classification, 7/10 lepidic, 63.2％ (48/76) papillary, and 5/8 micropapillary predominant adenocarcinomas harbored EGFR mutations. EGFR mutations showed significant difference among different histological subtypes (P =0.008). KRAS mutations were most frequently found in invasive mucinous adenocarcinoma (1/2),followed by colloid predominant adenocarcinoma (3/7). There was siguificant difference of KRAS mutations among different histological subtypes ( P =0.003 ).EMLA-ALK fusions were most frequently found in the solid predominant with mucin production subtype ( 15.4％,6/39),followed by colloid predominant adenocarcinoma ( 1/7 ),and no significant difference of EMLA-ALK fusions was found among different histological subtypes ( P =0.181 ). Significant TTF-1 overexpression was observed in adenocarcinomas harbored EGFR mutations (P =0.008 ),and no or significantly lower level expression of TTF-1 was observed in adenocarcinomas harbored KRAS mutations (P =0.000). However,there was no association between TTF-1 expression and EML4-ALK fusions ( P =0.274 ). Based on the 2004 WHO classification,mutations of KRAS ( P =0.002 ) and EML4-ALK (P =0.000),rather than EGFR ( P =0.502),showed significant differences among different subtypes. According to both classification systems,the difference of " triple negative" adenocarcinomas was not significant among different subtypes ( P =0.684,P =0.449, respectively ). Conclusions The new classification, combined with TTF-1 immunomarker,can help to predict the molecular alterations of EGFR and KRAS genes,but can not indicate the EML4-ALK fusion in lung adenocarcinoma. Lepidic, papillary, and micropapillary predominant adenocarcinomas with TTF-1 expression are closely related to the presence of EGFR mutation,and invasive mucinous adenocarcinoma,while colloid predominant adenocarcinoma without TTF-1 expression is closely related to the presence of KRAS mutation.

Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Egfr Mutations and the Correlation with Gefitinib Therapy in Chinese Nsclc - A Systematic Review Based on Individual Patient Data from 5 Medical Centers in China.

A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component.

Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma (vol 8, pg 159, 2017)

The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes

Correlation of EGFR Mutation and Histological Subtype According to the IASLC/ATS/ERS Classification of Lung Adenocarcinoma.

Prognostic Significance of the IASLC/ATS/ERS Classification in Chinese Patients—a Single Institution Retrospective Study of 292 Lung Adenocarcinoma

Correlation of Survival and EGFR Mutation with Predominant Histologic Subtype According to the New Lung Adenocarcinoma Classification in Stage IB Patients

Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival

Genotype-phenotype correlation in Chinese patients with pulmonary mixed type adenocarcinoma: Relationship between histologic subtypes, TITF-1/SP-A expressions and EGFR mutations

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification

Genomic and Immunological Features of Micropapillary Pattern in Lung Adenocarcinoma

Is MPP a Good Prognostic Factor in Stage III Lung Adenocarcinoma with EGFR Exon 19 Mutation?

The Mutation Profile of EGFR in Resectable Chinese Lung Cancer Patients.

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma

The prognostic impact of epidermal growth factor receptor mutation in clinical stage I lung adenocarcinoma

Clinicopathologic Features and Prognostic Value of Epidermal Growth Factor Receptor Mutation in Patients with Pt1a and Pt1b Invasive Lung Adenocarcinoma after Surgical Resection

The Clinicopathological and Molecular Characteristics of Resected EGFR‐mutant Lung Adenocarcinoma

Prognostic Value of Epidermal Growth Factor Receptor Gene Mutation in Resected Lung Adenocarcinoma